Maven Securities’s Pfizer PFE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$739K Buy
+26,366
New +$702K 0.01% 345
2025
Q4
Sell
-25,415
Closed -$641K 521
2025
Q3
$647K Buy
+25,415
New +$627K 0.02% 397
2024
Q2
Sell
-40,698
Closed -$1.13M 984
2024
Q1
$1.13M Buy
40,698
+24,974
+159% +$693K 0.07% 135
2023
Q4
$453K Buy
15,724
+7,618
+94% +$230K 0.01% 691
2023
Q3
$269K Sell
8,106
-27,653
-77% -$978K ﹤0.01% 971
2023
Q2
$1.31M Buy
+35,759
New +$1.39M 0.02% 380
2023
Q1
Sell
-9,857
Closed -$426K 1034
2022
Q4
$501K Sell
9,857
-24,329
-71% -$1.17M 0.01% 580
2022
Q3
$1.5M Buy
34,186
+26,265
+332% +$1.28M 0.03% 391
2022
Q2
$415K Buy
+7,921
New +$404K 0.01% 642
2021
Q4
Sell
-7,857
Closed -$389K 1092
2021
Q3
$338K Sell
7,857
-16,734
-68% -$741K 0.01% 800
2021
Q2
$963K Buy
24,591
+18,842
+328% +$733K 0.04% 458
2021
Q1
$209K Buy
+5,749
New +$204K 0.01% 909
2020
Q4
Sell
-7,648
Closed -$265K 786
2020
Q3
$265K Sell
7,648
-1,593
-17% -$55.9K 0.02% 506
2020
Q2
$284K Sell
9,241
-5,054
-35% -$172K 0.02% 420
2020
Q1
$443K Buy
+14,295
New +$487K 0.05% 195

Other funds holding PFE

Maven Securities's PFE Position: Q1 2026 in Review

Maven Securities opened a new position in Pfizer (PFE) in Q1 2026: 26,366 shares worth $739K. The stake represents 0.01% of the portfolio and ranks #345 among its holdings. This is a return to the name: Maven Securities previously reported a position in PFE as recently as Q3 2025.

Maven Securities first reported a position in PFE in Q1 2020 and has held it in 15 quarters since. The position peaked at $1.5M in Q3 2022. 2,937 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Maven Securities held 26,366 shares of Pfizer worth $739K as of Q1 2026.
  • Pfizer was a new Maven Securities position in Q1 2026.
  • Pfizer made up 0.01% of Maven Securities's portfolio in Q1 2026, its #345 holding.
  • Maven Securities first reported a position in Pfizer in Q1 2020 and has held it in 15 quarters since.
  • Maven Securities's Pfizer position peaked at $1.5M in Q3 2022.
  • 2,937 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Maven Securities's 13F filing for Q1 2026, filed 15 May 2026.